6-Chloropyridazine-3-carbonitrile

Catalog No. :
ACBQSI259
CAS No. :
35857-89-7
Molecular Formula :
C5H2ClN3
Molecular Weight :
139.54

IUPAC Name:6-chloropyridazine-3-carbonitrile

6-Chloropyridazine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$89.00Login to see priceIn stockInquiry
10g97%$149.00Login to see priceIn stockInquiry
25g97%$297.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloropyridazine-3-carbonitrile
IUPAC Name6-chloropyridazine-3-carbonitrile
MDL No.MFCD09835352
Molecular FormulaC5H2ClN3
Molecular Weight139.54
SMILESClC1=CC=C(N=N1)C#N
InChI KeyYMUOLGNUZURDEW-UHFFFAOYSA-N
Synonym3-CHLORO-6-CYANOPYRIDAZINE | AKOS005206933 | SY009543 | YMUOLGNUZURDEW-UHFFFAOYSA-N | EN300-80756 | FT-0650403 | PB28049 | 3-PYRIDAZINECARBONITRILE, 6-CHLORO- | F2147-0172 | Z1198233597 | J-518645 | 3-Chloro-6-cyanopyridazine;3-Pyridazinecarbonitrile, 6-c
CAS No.35857-89-7
PubChem CID13382871

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACBQSI259 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTDYX265 route compound structure diagram
    ACTDYX265135034-10-5
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACBQSI259 route product structure diagram
    ACBQSI25935857-89-7 In Stock
Inquiry

2. ACBQSI259 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNROZ260 route compound structure diagram
    ACNROZ260141-30-0 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACBQSI259 route product structure diagram
    ACBQSI25935857-89-7 In Stock
Inquiry

Comments (0)